                         SEQUENCE LISTING

<110>  The Board of Trustees of the Leland Stanford Junior 
       University
       European Molecular Biology Laboratory
 
<120>  METHODS OF TREATMENT, GENETIC SCREENING, AND DISEASE MODELS FOR 
       HEART CONDITIONS ASSOCIATED WITH RBM20 DEFICIENCY

<130>  STAN-1549WO (S18-210)

<150>  62/753,034
<151>  2018-10-30

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Forward Guide 2 oligonucleoitide for sgRNA cloning


<220>
<221>  source
<222>  (1)..(25)
<223>  sequence is synthesized

<400>  1
caccgctcac cggactacga gaccg                                             25


<210>  2
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Reverse Guide 2 oligonucleoitide for sgRNA cloning


<220>
<221>  source
<222>  (1)..(25)
<223>  sequence is synthesized

<400>  2
aaaccggtct cgtagtccgg tgagc                                             25


<210>  3
<211>  127
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  R634Q KI donor polynucleotide


<220>
<221>  source
<222>  (1)..(127)
<223>  sequence is synthesized

<400>  3
tgtgggacct cggggagagt gaccggctca ccggactacg agactgcggc ctttctgggc       60

catatctgtg agggagccaa ggagcaggat ttagaatctt cacacctccc atcccacccc      120

acccaca                                                                127


<210>  4
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RBM20 forward PCR primer


<220>
<221>  source
<222>  (1)..(22)
<223>  sequence is synthesized

<400>  4
ctggactagg gcaatcttgc cc                                                22


<210>  5
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RBM20 reverse PCR primer


<220>
<221>  source
<222>  (1)..(22)
<223>  sequence is synthesized

<400>  5
ctcattctgc ttggccttgg cg                                                22


